These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3071825)

  • 41. [Use of OKT3 monoclonal antibodies and anti-TAC for the quantitative evaluation of interleukin-2].
    Cornaglia-Ferraris P; Baffico M
    Boll Ist Sieroter Milan; 1985; 64(6):471-4. PubMed ID: 3938289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of in-vivo administration of a monoclonal antibody specific for the interleukin-2 receptor on the acute graft-versus-host reaction in mice.
    Volk HD; Brocke S; Osawa H; Diamantstein T
    Clin Exp Immunol; 1986 Oct; 66(1):126-31. PubMed ID: 3100116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prolongation of primate renal allografts with anti-Tac monoclonal antibody.
    Reed MH; Shapiro ME; Strom TB; Milford EL; Carpenter CB; Letvin NL; Waldmann TA; Kirkman RL
    Curr Surg; 1988; 45(1):28-30. PubMed ID: 3126026
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment with anti-interleukin-2 receptor monoclonal antibody.
    Strom TB; Gaulton GN; Kelley VE; Diamanstein T; Kupiec-Weglinski J; Tilney NL; Kirkman RL
    Prog Clin Biol Res; 1986; 224():227-38. PubMed ID: 3099309
    [No Abstract]   [Full Text] [Related]  

  • 45. Receptors in immunology.
    Gmelig Meyling FH
    Neth J Med; 1985; 28(2):63-8. PubMed ID: 3919325
    [No Abstract]   [Full Text] [Related]  

  • 46. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
    Schmidt RE; Hercend T; Fox DA; Bensussan A; Bartley G; Daley JF; Schlossman SF; Reinherz EL; Ritz J
    J Immunol; 1985 Jul; 135(1):672-8. PubMed ID: 3923116
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti T11 monoclonal antibodies activate human natural killer (NK) cells via the T11/E rosette receptor.
    Schmidt RE
    Beitr Infusionther Klin Ernahr; 1987; 18():266-71. PubMed ID: 3501949
    [No Abstract]   [Full Text] [Related]  

  • 48. Unusual expression of IL 2 receptors and both the c-myb and c-raf oncogenes in T cell lines and clones derived from autoimmune MRL-lpr/lpr mice.
    Rosenberg YJ; Malek TR; Schaeffer DE; Santoro TJ; Mark GE; Steinberg AD; Mountz JD
    J Immunol; 1985 May; 134(5):3120-3. PubMed ID: 3920313
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Internalization of interleukin 2 (IL-2) by high affinity IL-2 receptors is required for the growth of IL-2-dependent T cell lines.
    Kumar A; Moreau JL; Gibert M; Thèze J
    J Immunol; 1987 Dec; 139(11):3680-4. PubMed ID: 3119713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of functional human interleukin-2 receptor in mouse T cells by cDNA transfection.
    Kondo S; Shimizu A; Maeda M; Tagaya Y; Yodoi J; Honjo T
    Nature; 1986 Mar 6-12; 320(6057):75-7. PubMed ID: 3081815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synergism between anti-interleukin 2 receptor monoclonal antibody and cyclosporine in small-intestinal transplantation.
    Koltun WA; Diamantstein T; Kirkman RL
    Curr Surg; 1987; 44(4):315-8. PubMed ID: 3117495
    [No Abstract]   [Full Text] [Related]  

  • 52. Blockade of interleukin-13-mediated cell activation by a novel inhibitory antibody to human IL-13 receptor alpha1.
    Krause S; Behrends J; Borowski A; Lohrmann J; Lang S; Myrtek D; Lorenzen T; Virchow JC; Luttmann W; Friedrich K
    Mol Immunol; 2006 Apr; 43(11):1799-807. PubMed ID: 16364441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A monoclonal antibody specific for the murine IL-6-receptor inhibits the growth of a mouse plasmacytoma in vivo.
    Coulie PG; Vink A; Van Snick J
    Curr Top Microbiol Immunol; 1990; 166():43-6. PubMed ID: 2073815
    [No Abstract]   [Full Text] [Related]  

  • 54. The interleukin-1 receptor.
    Sims JE; Dower SK
    Year Immunol; 1989-1990; 6():112-26. PubMed ID: 2534977
    [No Abstract]   [Full Text] [Related]  

  • 55. High and low affinity IL 2 receptors: analysis by IL 2 dissociation rate and reactivity with monoclonal anti-receptor antibody PC61.
    Lowenthal JW; Corthésy P; Tougne C; Lees R; MacDonald HR; Nabholz M
    J Immunol; 1985 Dec; 135(6):3988-94. PubMed ID: 3934270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High- and low-affinity interleukin 2 receptors: distinctive effects of monoclonal antibodies.
    Fujii M; Sugamura K; Nakai S; Tanaka Y; Tozawa H; Hinuma Y
    J Immunol; 1986 Sep; 137(5):1552-6. PubMed ID: 3091684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies on T lymphocyte activation. II. Monoclonal antibody inhibiting the capacity of rat T lymphoblasts to absorb and to respond to IL-2: an anti-IL-2 receptor antibody?
    Osawa H; Diamantstein T
    Immunology; 1983 Mar; 48(3):617-21. PubMed ID: 6600707
    [TBL] [Abstract][Full Text] [Related]  

  • 58. T-cell receptor-based immunointervention in autoimmune diseases. Therapeutic use of monoclonal antibodies.
    Chatenoud L; Bach JF
    Immunol Ser; 1993; 59():101-16. PubMed ID: 7681694
    [No Abstract]   [Full Text] [Related]  

  • 59. [Analysis of IL-3 receptor using monoclonal antibodies].
    Ohta Y; Sugawara M
    Tanpakushitsu Kakusan Koso; 1988 Sep; 33(11):1819-23. PubMed ID: 3071825
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.